Biogen (NasdaqGS:BIIB) M&A announcement March 31, 2026 08:30 AM ET Company ParticipantsAdam Keeney - Head of Corporate DevelopmentAlisha Alaimo - President and Head of North AmericaChris Viehbacher - President and CEOEmily Field - Director and Head of U.S. Biopharmaceuticals Equity ResearchEvan Seigerman - Managing Director and Head of Healthcare ResearchJason Zemansky - VP in Biotechnology and Pharmaceuticals Equity ResearchKevin Meli - Senior Equity Research Associate in BiotechnologyMichael Yee - Managin ...